Mypart Injection 100 IU/ml contains Insulin Aspart (Protamine Crystallised), a fast-acting and intermediate-acting insulin formulation used for the management of diabetes mellitus. This insulin is designed to provide both rapid onset of action and prolonged glycemic control, making it suitable for controlling blood sugar levels in patients with type 1 and type 2 diabetes.
Insulin Aspart is a recombinant human insulin analogue with a modified amino acid sequence that allows it to be absorbed quickly into the bloodstream after injection. The protamine crystallised component delays its absorption, extending its action to provide basal insulin coverage. This dual-phase mechanism helps manage both postprandial (after meals) blood glucose spikes and fasting glucose levels, closely mimicking the natural insulin profile of the human body.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Mypart Injection 100 IU/ml is indicated for:
Type 1 diabetes mellitus – as part of a multiple daily injection regimen or insulin pump therapy
Type 2 diabetes mellitus – when oral antidiabetic medications alone are insufficient to achieve glycemic control
Management of hyperglycemia in diabetic patients requiring both rapid and intermediate-acting insulin
Patients needing basal and prandial glucose control with fewer daily injections compared to separate insulin formulations
This insulin formulation provides flexible dosing options to help achieve individualized glycemic targets under the supervision of a healthcare professional.
Rapid-acting component controls post-meal blood sugar spikes
Protamine crystallised component provides extended basal insulin effect
Mimics physiological insulin release, improving glycemic management
Can reduce the risk of hypoglycemia compared to conventional insulin therapy
Suitable for both adults and pediatric patients (as prescribed)
Mypart Injection helps patients maintain stable blood glucose levels, reducing complications associated with long-term diabetes, such as neuropathy, retinopathy, and cardiovascular disease.
The dose of Mypart Injection 100 IU/ml must be individualized based on the patient’s blood glucose levels, diet, physical activity, and concurrent medications.
Administer subcutaneously in the abdomen, thigh, or upper arm. Rotate injection sites to prevent lipodystrophy.
Blood glucose monitoring is essential to adjust the dose and timing of injections.
Do not mix with other insulins unless specified by a healthcare provider.
Follow strict hygiene protocols while handling and injecting the medication.
Hypoglycemia is a potential risk; patients should be aware of early symptoms such as sweating, dizziness, or palpitations.
Adjustments may be necessary during illness, stress, or changes in diet and activity levels.
Inform your physician about all medications to prevent interactions affecting blood glucose.
Pregnancy and lactation require careful monitoring under medical supervision.
Always carry a source of fast-acting sugar to manage unexpected hypoglycemic episodes.
Common side effects may include:
Hypoglycemia (low blood sugar)
Injection site reactions, such as redness, swelling, or itching
Weight gain with long-term therapy
Rare allergic reactions, including rash or anaphylaxis
Monitoring and timely adjustments minimize adverse effects and ensure safe use.
Store unopened Mypart Injection 100 IU/ml in a refrigerator at 2–8°C. Do not freeze. Once opened, it can be kept at room temperature (below 30°C) for up to 28 days. Protect from light and keep out of reach of children.
Mypart Injection 100 IU/ml (Insulin Aspart [Protamine Crystallised]) is a reliable insulin therapy that provides both rapid and intermediate glycemic control, helping diabetic patients achieve stable blood sugar levels and improve overall health outcomes.
Login Or Registerto submit your questions to seller
No none asked to seller yet